Delivery Order SPE2DB22D2206-SPE2DB24FGS31
Award Date 4/16/24
Potential Completion Date 5/7/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $59,560.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which is a Delivery Order, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. The contract has a firm fixed price and a completion date of September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tecvayli 153 mg/1.7 mL vials, a pharmaceutical product, with a ceiling value of $17,802.18. This firm fixed price delivery order, awarded on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,802.15 for TECVAYLI 153 mg/1.7 ml vials on October 29, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TECVAYLI is a prescription pharmaceutical product, reflecting the agency's ongoing need to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order contract is for the supply of Talvey 40 mg/ml vials. The contract has an ultimate completion date of April 30, 2025 and is not designated with a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Tecvayli 153 mg/1.7 mL vials. This firm fixed price delivery order, valued at $11,868.12, represents a competitively awarded non-set-aside procurement with an ultimate completion date of September 18, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical on February 1, 2025. The $11,340.40 firm fixed-price delivery order has a completion date of February 3, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $35,638.65 with a completion date of November 12, 2024. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,594.50, is a delivery order for the supply of Tecentriq Hybreza 1,875 mg 15 ml, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...